HPV Self-collection with BD Onclarity™ HPV Assay

The diagnostic accuracy of BD Onclarity™ HPV Assay for the detection of CIN2+ is equivalent with self-collected and clinician-collected samples.^{7, 8}

relative sensitivity for CIN2+ detection*

In a study comparing the performance of six PCR-based HPV tests on self-collected samples, the BD Onclarity™ HPV Assay was found to have the lowest proportion of invalid results with self-collected samples.⁹

In addition, there was a significant difference in the proportion of invalids between self- and clinician-collected samples on all HPV tests, except BD Onclarity™ HPV Assay.⁹

The BD Onclarity™ HPV Assay offers a validated, convenient logistical chain from sample to testing that supports the expansion of self-collection for cervical cancer screening

• A vaginal sample is self-obtained by a person with a cervix either at home or at a clinic using an approved collection device.
• The sample is transported to the laboratory dry within 30 days of collection at 2–30 ºC.†
• The sample is transferred to a BD Onclarity™ HPV Self Collection Diluent Tube and can be stored up to 15 days at -20–30 ºC.
• The self-collected sample is tested using the BD Onclarity™ HPV Assay on the BD Viper™ LT System or the BD COR™ System.